FollowMyHealth Patient Portal

Matthew A. Powell, MD

Associate Professor, Obstetrics and Gynecology
Chief, Division of Gynecologic Oncology

Specialty Areas

Gynecologic Oncology
Cervical Cancer
Ovarian Cancer
Endometrial Cancer

Board Certifications

Gynecologic Oncology
Obstetrics and Gynecology

Hospital Affiliations

Barnes-Jewish Hospital
Missouri Baptist Medical Center
St. Louis Children's Hospital
Progress West Hospital

Areas of Clinical Interest

Gynecologic oncology, endometrial cancer, vulva carcinoma, ovarian cancer, cervical cancer, adnexal masses, tumors, hysterectomy, lymphadenectomy, endometrial adenocarcinomas, cervical intraepithelial neoplasia, gynecologic malignancies, ob/gyn, women's health

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Missouri Baptist Medical Center
Building D

3023 N. Ballas Road
Fourth Floor, Suite 450
St. Louis, MO 63131

Floor: Building D, Fourth Floor, Suite 450
Office Phone: 314-996-6075
Fax: 314-996-6074

Center for Advanced Medicine
Gynecologic Treatment Center

4921 Parkview Place
St. Louis, MO 63110

Suite: C
Floor: 13
Office Phone: 314-362-3181
Fax: 314-362-8644

Education

Education

Fellowship: Gynecologic Oncology, Washington University School of Medicine, St. Louis, Missouri 2002
Residency: Obstetrics and Gynecology, Ohio State University Hospital and Clinics, Columbus, Ohio 1999
Medical Degree: Michigan State University College of Human Medicine, East Lansing, Michigan 1995
B.S.: Biochemistry and Biophysics, Washington State University, Pullman, Washington 1990
Research Fellow: University of Washington, Northwest College and University Association for Science, Richland, Washington 1989

Publication & Research

Publication & Research

Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer.
Kuroki LM, Jin X, Dmitriev IP, Kashentseva EA, Powell MA, Mutch DG, Dietz AB, Curiel DT, Hawkins WG, Spitzer D
PLoS One. 2017; 12(12)e0190125. doi: 10.1371/journal.pone.0190125.

PMID:
    29267342
    [PubMed - in process]
Related citations


Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits.
Zamorano AS, Wan L, Powell MA, Massad LS
Gynecol Oncol Rep. 2017 Nov; 2248-51. doi: 10.1016/j.gore.2017.09.003.

PMID:
    29234709
    [PubMed]
Related citations


An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.
Cosgrove CM, Tritchler DL, Cohn DE, Mutch DG, Rush CM, Lankes HA, Creasman WT, Miller DS, Ramirez NC, Geller MA, Powell MA, Backes FJ, Landrum LM, Timmers C, Suarez AA, Zaino RJ, Pearl ML, DiSilvestro PA, Lele SB, Goodfellow PJ
Gynecol Oncol. 2018 Jan; 148(1)174-180. doi: 10.1016/j.ygyno.2017.10.037.

PMID:
    29132872
    [PubMed - in process]
Related citations


Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
Markovina S, Wang S, Henke LE, Luke CJ, Pak SC, DeWees T, Pfeifer JD, Schwarz JK, Liu W, Chen S, Mutch D, Wang X, Powell MA, Siegel BA, Dehdashti F, Silverman GA, Grigsby PW
Br J Cancer. 2018 Jan; 118(1)72-78. doi: 10.1038/bjc.2017.390.

PMID:
    29112685
    [PubMed - in process]
Related citations


Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer.
Binder PS, Kuroki LM, Zhao P, Cusworth S, Divine LM, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Massad LS
Gynecol Oncol. 2017 Nov; 147(2)309-314. doi: 10.1016/j.ygyno.2017.08.031.

PMID:
    28916118
    [PubMed - indexed for MEDLINE]
Related citations


Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.
Palisoul ML, Quinn JM, Schepers E, Hagemann IS, Guo L, Reger K, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC
Mol Cancer Ther. 2017 Dec; 16(12)2881-2891. doi: 10.1158/1535-7163.MCT-17-0587.

PMID:
    28904132
    [PubMed - in process]
Related citations


The effect of a multidisciplinary palliative care initiative on end of life care in gynecologic oncology patients.
Mullen MM, Divine LM, Porcelli BP, Wilkinson-Ryan I, Dans MC, Powell MA, Mutch DG, Hagemann AR, Thaker PH
Gynecol Oncol. 2017 Nov; 147(2)460-464. doi: 10.1016/j.ygyno.2017.08.002.

PMID:
    28784245
    [PubMed - indexed for MEDLINE]
Related citations


Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: Treatment technique and outcomes.
Rao YJ, Chundury A, Schwarz JK, Hassanzadeh C, DeWees T, Mullen D, Powell MA, Mutch DG, Grigsby PW
Adv Radiat Oncol. 2017 Apr-Jun; 2(2)148-158. doi: 10.1016/j.adro.2017.02.006.

PMID:
    28740926
    [PubMed]
Related citations


Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.
Rao YJ, Chin RI, Hui C, Mutch DG, Powell MA, Schwarz JK, Grigsby PW, Markovina S
Gynecol Oncol. 2017 Sep; 146(3)572-579. doi: 10.1016/j.ygyno.2017.06.022.

PMID:
    28662775
    [PubMed - indexed for MEDLINE]
Related citations


Wound Complication Rates After Staples or Suture for Midline Vertical Skin Closure in Obese Women: A Randomized Controlled Trial.
Kuroki LM, Mullen MM, Massad LS, Wu N, Liu J, Mutch DG, Powell MA, Hagemann AR, Thaker PH, McCourt CK, Novetsky AP
Obstet Gynecol. 2017 Jul; 130(1)91-99. doi: 10.1097/AOG.0000000000002061.

PMID:
    28594761
    [PubMed - indexed for MEDLINE]
Related citations


Which patients with inoperable vulvar cancer may benefit from brachytherapy in addition to external beam radiation? A Surveillance, Epidemiology, and End Results analysis.
Rao YJ, Hui C, Chundury A, Schwarz JK, DeWees T, Powell MA, Mutch DG, Grigsby PW
Brachytherapy. 2017 Jul - Aug; 16(4)831-840. doi: 10.1016/j.brachy.2017.03.012.

PMID:
    28533162
    [PubMed]
Related citations


Endometrial adenosarcoma in the setting of a germline <i>DICER1</i> mutation: A case report.
Mullen MM, Divine LM, Hagemann IS, Babb S, Powell MA
Gynecol Oncol Rep. 2017 May; 20121-124. doi: 10.1016/j.gore.2017.04.004.

PMID:
    28459098
    [PubMed]
Related citations


Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.
Ioffe YJ, Massad LS, Powell MA, Hagemann AR, Mutch DG, Thaker PH, Schwarz JK, Grigsby PW
Gynecol Obstet Invest. 2017 Apr 8; doi: 10.1159/000458706.

PMID:
    28399524
    [PubMed - as supplied by publisher]
Related citations


Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol.
Creasman WT, Ali S, Mutch DG, Zaino RJ, Powell MA, Mannel RS, Backes FJ, DiSilvestro PA, Argenta PA, Pearl ML, Lele SB, Guntupalli SR, Waggoner S, Spirtos N, Boggess JF, Edwards RP, Filiaci VL, Miller DS
Gynecol Oncol. 2017 Jun; 145(3)519-525. doi: 10.1016/j.ygyno.2017.03.017.

PMID:
    28392124
    [PubMed - indexed for MEDLINE]
Related citations


A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Jandial DA, Brady WE, Howell SB, Lankes HA, Schilder RJ, Beumer JH, Christner SM, Strychor S, Powell MA, Hagemann AR, Moore KN, Walker JL, DiSilvestro PA, Duska LR, Fracasso PM, Dizon DS
Gynecol Oncol. 2017 May; 145(2)236-242. doi: 10.1016/j.ygyno.2017.03.013.

PMID:
    28341300
    [PubMed - indexed for MEDLINE]
Related citations


Association of post-treatment positron emission tomography with locoregional control and survival after radiation therapy for squamous cell carcinoma of the vulva.
Rao YJ, Hassanzadeh C, Chundury A, Hui C, Siegel BA, Dehdashti F, DeWees T, Mullen D, Powell MA, Mutch DG, Schwarz JK, Grigsby PW
Radiother Oncol. 2017 Mar; 122(3)445-451. doi: 10.1016/j.radonc.2016.12.019.

PMID:
    28063696
    [PubMed - indexed for MEDLINE]
Related citations


A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group study.
McCourt CK, Deng W, Dizon DS, Lankes HA, Birrer MJ, Lomme MM, Powell MA, Kendrick JE, Saltzman JN, Warshal D, Tenney ME, Kushner DM, Aghajanian C
Gynecol Oncol. 2017 Jan; 144(1)101-106. doi: 10.1016/j.ygyno.2016.10.026.

PMID:
    28029447
    [PubMed - indexed for MEDLINE]
Related citations


Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
Winder AD, Maniar KP, Wei JJ, Liu D, Scholtens DM, Lurain JR, Schink JC, Buttin BM, Filiaci VL, Lankes HA, Ramirez NC, Park K, Singh M, Lieberman RW, Mannel RS, Powell MA, Backes FJ, Mathews CA, Pearl ML, Secord AA, Peace DJ, Mutch DG, Creasman WT, Kim JJ
Cancer. 2017 Apr 1; 123(7)1144-1155. doi: 10.1002/cncr.30477.

PMID:
    27926776
    [PubMed - indexed for MEDLINE]
Related citations


SGO Health Policy and Socioeconomic Committee: Current and Future Efforts of the Coding and Reimbursement Taskforce and the Policy, Quality and Outcomes Taskforce.
Goff BA, Shahin MS, Powell MA, Dowdy SC
Gynecol Oncol. 2016 Nov; 143(2)229-230. doi: 10.1016/j.ygyno.2016.09.022.

PMID:
    27692694
    [PubMed - indexed for MEDLINE]
Related citations


Reply.
Binder PS, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK, Peipert JF, Kallogjeri D, Brooks RA
Am J Obstet Gynecol. 2017 Feb; 216(2)192-193. doi: 10.1016/j.ajog.2016.09.084.

PMID:
    27640937
    [PubMed - in process]
Related citations